The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
FAK in cancer: mechanistic findings and clinical applications
Open accessAbstract
Focal adhesion kinase (FAK) is a cytoplasmic protein tyrosine kinase that is overexpressed and activated in several advanced-stage solid cancers. FAK promotes tumour progression and metastasis through effects on cancer cells, as well as stromal cells of the tumour microenvironment. The kinase-dependent and kinase-independent functions of FAK control cell movement, invasion, survival, gene expression and cancer stem cell self-renewal. Small molecule FAK inhibitors decrease tumour growth and metastasis in several preclinical models and have initial clinical activity in patients with limited adverse events. In this Review, we discuss FAK signalling effects on both tumour and stromal cell biology that provide rationale and support for future therapeutic opportunities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, multiple previous studies have implicated FAK activation in the development of resistance against various chemotherapy agents through its regulation of the tumor microenvironment.[ 11, 15, 44 ]”
From Focal Adhesion Kinase (FAK) Inhibition Synergizes with KRAS G12C Inhibitors in Treating Cancer through the Regulation of the FAK–YAP Signaling (2021) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
The protein kinase complement of the human genome
Manning, G., Whyte, D. B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002) · Science · doi:10.1126/science.1075762 · Cited by 8,145
Integrated genomic analyses of ovarian carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,927
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
Focal adhesion kinase: in command and control of cell motility
Mitra, S. K., Hanson, D. A., & Schlaepfer, D. D. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1549 · Cited by 2,657
Self-citationFocal adhesion kinase: the first ten years
Parsons, J. T. (2003) · Journal of Cell Science · doi:10.1242/jcs.00373 · Cited by 1,389
The role of focal-adhesion kinase in cancer — a new therapeutic opportunity
McLean, G. W., Carragher, N. O., Avizienyte, E., EVANS, J., Brunton, V. G., & Frame, M. C. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1647 · Cited by 1,049
E-cadherin–integrin crosstalk in cancer invasion and metastasis
Canel, M., Serrels, A., Frame, M. C., & Brunton, V. G. (2013) · Journal of Cell Science · doi:10.1242/jcs.100115 · Cited by 651
Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions
Schaller, M. D. (2010) · Journal of Cell Science · doi:10.1242/jcs.045112 · Cited by 613
Signal transduction by focal adhesion kinase in cancer
Zhao, J., & Guan, J. (2009) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9165-4 · Cited by 608
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 1,000
Luo, W., Wen, T., & Qu, X. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02935-3 · Cited by 73
Ma, G., Liu, H., Hua, Q., Wang, M., Du, M., Lin, Y., Ge, Y., Gong, W., Zhao, Q., Qiang, F., et al. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0613-z · Cited by 68
Role of Focal Adhesion Kinase in Small-Cell Lung Cancer and Its Potential as a Therapeutic Target
Nana, F. A., Vanderputten, M., & Ocak, S. (2019) · Cancers · doi:10.3390/cancers11111683 · Cited by 69
Lechertier, T., Reynolds, L. E., Kim, H., Pedrosa, A., Gómez-Escudero, J., Muñoz‐Félix, J. M., Batista, S., Dukinfield, M., Demircioglu, F., Wong, P., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16618-6 · Cited by 72
Mo, C., Li, ., Yang, S.-X., Guo, H., Liu, Y., Luo, X.-Y., Wang, Y., Li, J., Li, J., & Zou, Q. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0970-z · Cited by 68
Park, S.-A., Kim, M.-J., Park, S., Kim, J.-S., Lim, W., Nam, J., & Sheen, Y. Y. (2015) · Scientific Reports · doi:10.1038/srep16492 · Cited by 68
Ramos, G. D. O., Bernardi, L., Lauxen, I. D. S., Filho, M. S., Horwitz, A. R., & Lamers, M. L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151338 · Cited by 68
Focal Adhesion Kinase: Insight into Molecular Roles and Functions in Hepatocellular Carcinoma
Panera, N., Crudele, A., Romito, I., Gnani, D., & Alisi, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010099 · Cited by 69
de Jonge, M. J. A., Steeghs, N., Lolkema, M. P., Hotte, S. J., Hirte, H. W., van der Biessen, D. A. J., Razak, A. R. A., Vos, F. D., Verheijen, R. B., Schnell, D., et al. (2019) · Targeted Oncology · doi:10.1007/s11523-018-00617-1 · Cited by 67
Kanda, M., Shimizu, D., Sawaki, K., Nakamura, S., Umeda, S., Miwa, T., Tanaka, H., Tanaka, C., Hayashi, M., Iguchi, Y., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01251-0 · Cited by 67
Tao, Y., Xing, S., Zuo, S., Bao, P., Jin, Y., Li, Y., Li, M., Wu, Y., Chen, S., Wang, X., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101281 · Cited by 69
Role of c-Src in Carcinogenesis and Drug Resistance
Raji, L. M., Tetteh, A., & Amin, A. R. M. R. (2023) · Cancers · doi:10.3390/cancers16010032 · Cited by 67
Chan, K. K. L., Siu, M. K. Y., Jiang, Y., Wang, J., Wang, Y., Leung, T. H. Y., Liu, S. S., Cheung, A., & Ngan, H. (2017) · BMC Cancer · doi:10.1186/s12885-017-3601-1 · Cited by 67
The FAK inhibitor BI 853520 exerts anti-tumor effects in breast cancer
Tiede, S., Meyer-Schaller, N., Kalathur, R. K. R., Ivanek, R., Fagiani, E., Schmassmann, P., Stillhard, P., Häfliger, S., Kraut, N., Schweifer, N., et al. (2018) · Oncogenesis · doi:10.1038/s41389-018-0083-1 · Cited by 66
The cancer cell adhesion resistome: mechanisms, targeting and translational approaches
Dickreuter, E., & Cordes, N. (2016) · Biological Chemistry · doi:10.1515/hsz-2016-0326 · Cited by 67
Transforming targeted cancer therapy with PROTACs: A forward-looking perspective
Farnaby, W., Koegl, M., McConnell, D. B., & Ciulli, A. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.02.009 · Cited by 66
Hepatocyte phosphatase DUSP22 mitigates NASH-HCC progression by targeting FAK
Ge, C., Tan, J., Dai, X., Kuang, Q., Zhong, S., Lai, L., Yi, C., Sun, Y., Luo, J., Zhang, C., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33493-5 · Cited by 66
Ciavatta, M. L., Lefranc, F., Carbone, M., Mollo, E., Gavagnin, M., Betancourt, T., Dasari, R., Kornienko, A., & Robert Kiss, A. (2016) · Medicinal Research Reviews · doi:10.1002/med.21423 · Cited by 67
Increased extracellular matrix density disrupts E-cadherin/β-catenin complex in gastric cancer cells
Jang, M., Koh, I., Lee, J. E., Lim, J. Y., Cheong, J., & Kim, P. (2018) · Biomaterials Science · doi:10.1039/c8bm00843d · Cited by 67
Yu, J., Shi, L., Lin, W., Lu, B., & Zhao, Y. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113745 · Cited by 65
Siriwardena, B. S. M. S., Tsunematsu, T., Qi, G., Ishimaru, N., & Kudo, Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051462 · Cited by 64
Ovarian Cancer Stem Cells: Role in Metastasis and Opportunity for Therapeutic Targeting
Zong, X., & Nephew, K. P. (2019) · Cancers · doi:10.3390/cancers11070934 · Cited by 64
Talin‑1 interaction network in cellular mechanotransduction (Review)
Zhao, Y., Lykov, N., & Tzeng, C. (2022) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2022.5116 · Cited by 69
Chi, M., Evans, H. M., Gilchrist, J., Mayhew, J., Hoffman, A., Pearsall, E., Jankowski, H., Brzozowski, J. S., & Skelding, K. A. (2016) · Scientific Reports · doi:10.1038/srep33132 · Cited by 64
HGF/Met Signaling in Cancer Invasion: The Impact on Cytoskeleton Remodeling
Xiang, C., Chen, J., & Fu, P. (2017) · Cancers · doi:10.3390/cancers9050044 · Cited by 64
Hirt, U. A., Waizenegger, I. C., Schweifer, N., Haslinger, C., Gerlach, D., Braunger, J., Weyer-Czernilofsky, U., Stadtmüller, H., Sapountzis, I., Bader, G., et al. (2018) · Oncogenesis · doi:10.1038/s41389-018-0032-z · Cited by 63
Chuang, P., Hsiao, M., Hsu, T.-L., Chang, C., Wu, C., Chen, B.-R., Huang, H., Liao, K., Chen, C.-C., Chen, C., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1816946116 · Cited by 62
Metastasis: crosstalk between tissue mechanics and tumour cell plasticity
Coban, B., Bergonzini, C., Zweemer, A. J. M., & Danen, E. H. J. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01150-7 · Cited by 62
Sunami, Y., Häußler, J., & Kleeff, J. H. (2020) · Cancers · doi:10.3390/cancers12123770 · Cited by 66
Functional and clinical characteristics of focal adhesion kinases in cancer progression
Zhang, Z., Li, J., Jiao, S., Han, G., Zhu, J., & Liu, T. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1040311 · Cited by 66
Ma, K., Kwon, S. H., Padmanabhan, J., Duscher, D., Trotsyuk, A. A., Dong, Y., Inayathullah, M., Rajadas, J., & Gurtner, G. C. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.04.034 · Cited by 62
Wurzer, H., Hoffmann, C., Absi, A. A., & Thomas, C. (2019) · Cells · doi:10.3390/cells8050463 · Cited by 62
Loss of Ambra1 promotes melanoma growth and invasion
Leo, L. D., Bodemeyer, V., Bosisio, F. M., Claps, G., Carretta, M., Rizza, S., Faienza, F., Frías, A., Khan, S., Bordi, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22772-2 · Cited by 62
T-cell co-stimulation in combination with targeting FAK drives enhanced anti-tumor immunity
Canel, M., Taggart, D., Sims, A. H., Lonergan, D. W., Waizenegger, I. C., & Serrels, A. (2020) · eLife · doi:10.7554/elife.48092 · Cited by 62
Coordination of inter-organelle communication and lipid fluxes by OSBP-related proteins
Arora, A., Taskinen, J., & Olkkonen, V. M. (2022) · Progress in Lipid Research · doi:10.1016/j.plipres.2022.101146 · Cited by 64
Chen, J., Zhao, D., Zhang, L., Zhang, J., Xiao, Y., Wu, Q., Wang, Y., & Zhan, Q. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00903-z · Cited by 61
Xie, Y., Du, J., Liu, Z., Zhang, D., Yao, X., & Yang, Y. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-1020-z · Cited by 60
The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value
Cohen, P. A., Donini, C. F., Nguyen, N. T., Lincet, H., & Vendrell, J. A. (2015) · Oncotarget · doi:10.18632/oncotarget.5893 · Cited by 60
The effect of soluble E-selectin on tumor progression and metastasis
Kang, S. A., Blache, C. A., Bajaña, S., Hasan, N., Kamal, M. A., Morita, Y., Gupta, V., Tsolmon, B., Suh, K. S., Gorenstein, D. G., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2366-2 · Cited by 60
Gnani, D., Romito, I., Artuso, S., Chierici, M., Stefanis, C. D., Panera, N., Crudele, A., Ceccarelli, S., Carcarino, E., Doria, V., et al. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.34 · Cited by 60
Leptin induces cell migration and invasion in a FAK-Src-dependent manner in breast cancer cells
Juárez-Cruz, J. C., Zuñiga‐Eulogio, M. D., Olea‐Flores, M., Castañeda-Saucedo, E., Catalán, M. A. M., Ortuño‐Pineda, C., Moreno‐Godínez, M. E., Villegas‐Comonfort, S., Padilla‐Benavides, T., & Navarro‐Tito, N. (2019) · Endocrine Connections · doi:10.1530/ec-19-0442 · Cited by 60
Bimodal sensing of guidance cues in mechanically distinct microenvironments
Tabdanov, E. D., Puram, V. V., Win, Z., Alamgir, A., Alford, P. W., & Provenzano, P. P. (2018) · Nature Communications · doi:10.1038/s41467-018-07290-y · Cited by 59
The Non-receptor Tyrosine Kinase Pyk2 in Brain Function and Neurological and Psychiatric Diseases
de Pins, B., Mendes, T., Giralt, A., & Girault, J. (2021) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2021.749001 · Cited by 65
Natural Products with Activity against Lung Cancer: A Review Focusing on the Tumor Microenvironment
Yang, Y., Li, N., Wang, T., & Di, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910827 · Cited by 60
Liu, C., Li, Y., Xing, Y., Cao, B., Yang, F., Yang, T., Ai, Z., Wei, Y., & Jiang, J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.712976 · Cited by 60
AC1MMYR2 impairs high dose paclitaxel-induced tumor metastasis by targeting miR-21/CDK5 axis
Ren, Y., Zhou, X., Yang, J.-J., Liu, X., Zhao, X., Wang, Q.-X., Han, L., Song, X., Zhu, Z.-Y., Tian, W.-P., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.03.038 · Cited by 58
Chiu, K., Wu, C., Chia, C.-H., Hsu, S., & Tzeng, Y. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.11.046 · Cited by 60
Duperret, E. K., Dahal, A., & Ridky, T. W. (2015) · Journal of Cell Science · doi:10.1242/jcs.175539 · Cited by 59
Filliol, A. A., & Schwabe, R. F. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-1685539 · Cited by 60
Yao, L., Wu, L., Zhang, L., Zhou, W., Wu, L., He, K., Ren, J., Deng, Y., Yang, D., Wang, J., et al. (2020) · Oncogenesis · doi:10.1038/s41389-020-0198-z · Cited by 58
Angiopoietin 2 signal complexity in cardiovascular disease and cancer
Nicolini, G., Forini, F., Kusmic, C., Iervasi, G., & Balzan, S. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117080 · Cited by 57
Zhang, Q., Kounde, C. S., Mondal, M., Greenfield, J. L., Baker, J. R., Kotelnikov, S., Ignatov, M., Tinworth, C. P., Zhang, L., Conole, D., et al. (2022) · Chemical Communications · doi:10.1039/d2cc03092f · Cited by 58
α-Actinin-4 Enhances Colorectal Cancer Cell Invasion by Suppressing Focal Adhesion Maturation
Fukumoto, M., Kurisu, S., Yamada, T., & Takenawa, T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120616 · Cited by 57
Synergism of FAK and tyrosine kinase inhibition in Ph+ B-ALL
Churchman, M. L., Evans, K., Richmond, J., Robbins, A. K., Jones, L., Shapiro, I. M., Pachter, J. A., Weaver, D. T., Houghton, P. J., Smith, M. A., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.86082 · Cited by 58
Targeting adhesion signaling in KRAS, LKB1 mutant lung adenocarcinoma
Gilbert‐Ross, M., Konen, J. M., Koo, J., Shupe, J. A., Robinson, B. S., Wiles, W. G., Huang, C., Martin, W. D., Behera, M., Smith, G. H., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.90487 · Cited by 57
Braicu, C., Zimta, A.-A., Gulei, D., Olariu, A., & Berindan‐Neagoe, I. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03016-5 · Cited by 57
Pedrosa, A., Bodrug, N., Gómez-Escudero, J., Carter, E. P., Reynolds, L. E., Georgiou, P. N., Fernandez, I., Lees, D. M., Kostourou, V., Alexopoulou, A. N., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3934 · Cited by 57
Jung, W., Yam, N., Chen, C.-C., Elawad, K., Hu, B., & Chen, Y. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119756 · Cited by 58
Zhu, N., Hou, J., Ma, G., Guo, S., Zhao, C., & Chen, B. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01352-2 · Cited by 56
The role of matrix stiffness in cancer stromal cell fate and targeting therapeutic strategies
Wei, J., Yao, J., Yan, M., Xie, Y., Liu, P., Mao, Y., & Li, X. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.08.005 · Cited by 57
Yang, M. J., Xiang, H., & Luo, G. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116246 · Cited by 56
Vishnubalaji, R., Manikandan, M., Fahad, M., Hamam, R., Alfayez, M. A., Kassem, M. S., Aldahmash, A. M., & Alajez, N. M. (2018) · Oncotarget · doi:10.18632/oncotarget.24420 · Cited by 59
Sun, J., Luo, Q., Liu, L., & Song, G. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.04.015 · Cited by 55
The correlation and role analysis of COL4A1 and COL4A2 in hepatocarcinogenesis
Liu, Y., Zhang, J., Chen, Y., Sohel, H., Ke, X., Chen, J., & Li, Y. (2020) · Aging · doi:10.18632/aging.102610 · Cited by 55
miR-1298 Inhibits Mutant KRAS-Driven Tumor Growth by Repressing FAK and LAMB3
Zhou, Y., Dang, J., Chang, K.-Y., Yau, E., Aza-Blanc, P., Moscat, J., & Rana, T. M. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2936 · Cited by 54
Liang, N. N., Li, Y.-L., & Chung, H. Y. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4004 · Cited by 54
Targeting Protein Kinases Degradation by PROTACs
Yu, F., Cai, M., Shao, L., & Zhang, J. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.679120 · Cited by 55
Wen, H., Feng, Z., Ma, Y., Liu, R., Ou, Q., Guo, Q., Shen, Y. X., Wu, X., Shao, Y. W., Bao, H., et al. (2022) · BMC Cancer · doi:10.1186/s12885-022-09602-4 · Cited by 54
MicroRNA-92b represses invasion-metastasis cascade of esophageal squamous cell carcinoma
Ma, G., Jing, C., Lin, L., Huang, F., Ding, F., Wang, B., Lin, D., Luo, A., & Liu, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.7747 · Cited by 54
Nuclear FAK and Runx1 Cooperate to Regulate IGFBP3, Cell-Cycle Progression, and Tumor Growth
Canel, M., Byron, A., Sims, A. H., Cartier, J., Patel, H., Frame, M. C., Brunton, V. G., Serrels, B., & Serrels, A. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0418 · Cited by 54
Focal Adhesion Kinases in Platelet Function and Thrombosis
Guidetti, G. F., Torti, M., & Canobbio, I. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311787 · Cited by 54
To reveal pharmacological targets and molecular mechanisms of curcumol against interstitial cystitis
Wu, K., Wei, P., Liu, M., Liang, X., & Su, M. (2019) · Journal of Advanced Research · doi:10.1016/j.jare.2019.05.003 · Cited by 54
Overcoming immunotherapeutic resistance by targeting the cancer inflammation cycle
Wattenberg, M. M., & Beatty, G. L. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.01.002 · Cited by 54
Zhang, Y., Cheng, K., Xu, B., Shi, J., Qiang, J., Shi, S., Yi, Y., Li, H., Jin, T., Guo, R., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00652 · Cited by 53
Lorusso, G., Wyss, C. B., Kuonen, F., Vannini, N., Billottet, C., Duffey, N., Pineau, R., Lan, Q., Wirapati, P., Barras, D., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.aax8933 · Cited by 54
Poh, A. R., & Ernst, M. (2023) · Oncogene · doi:10.1038/s41388-023-02701-x · Cited by 54
Novel Role of Src in Priming Pyk2 Phosphorylation
Zhao, M., Finlay, D., Zharkikh, I. L., & Vuori, K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149231 · Cited by 53
Sunami, Y., Boeker, V., & Kleeff, J. H. (2021) · Cancers · doi:10.3390/cancers13040697 · Cited by 56
Focal Adhesion Kinase Fine Tunes Multifaced Signals toward Breast Cancer Progression
Rigiracciolo, D. C., Cirillo, F., Talia, M., Muglia, L., Gutkind, J. S., Maggiolini, M., & Lappano, R. (2021) · Cancers · doi:10.3390/cancers13040645 · Cited by 55
Murphy, K. J., Reed, D. A., Vennin, C., Conway, J. R. W., Nobis, M., Yin, J. X. M., Chambers, C. R., Pereira, B., Lee, V., Filipe, E. C., et al. (2021) · Science Advances · doi:10.1126/sciadv.abh0363 · Cited by 54
Chauhan, A., & Khan, T. A. (2020) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13808 · Cited by 52
Yang, X., Yang, L., Yang, D., Li, M., & Wang, P. (2022) · Nano Letters · doi:10.1021/acs.nanolett.2c00680 · Cited by 52
Spatial organization of PI3K-PI(3,4,5)P3-AKT signaling by focal adhesions
Wang, J., An, Z., Wu, Z., Zhou, W., Sun, P., Wu, P., Dang, S., Xue, R., Bai, X., Du, Y., et al. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.10.010 · Cited by 51
Oudart, J., Doué, M., Vautrin, A., Brassart, B., Sellier, C., Dupont-Deshorgue, A., Monboisse, J., Maquart, F., Brassart‐Pasco, S., & Ramont, L. (2015) · Oncotarget · doi:10.18632/oncotarget.6399 · Cited by 52
Yamazaki, S., Higuchi, Y., Ishibashi, M., Hashimoto, H., Yasunaga, M., Matsumura, Y., Tsuchihara, K., Tsuboi, M., Goto, K., Ochiai, A., et al. (2018) · Cancer Science · doi:10.1111/cas.13624 · Cited by 52
Parkin, A., Man, J., Timpson, P., & Pajic, M. (2019) · FEBS Journal · doi:10.1111/febs.15011 · Cited by 54
Paul, R., Luo, M., Mo, X., Lu, J. L., Yeo, S. K., & Guan, J. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01298-3 · Cited by 52
Medicinal applications of vanadium complexes with Schiff bases
Hashmi, K., Satya, S., Gupta, S., Siddique, A., Khan, T., & Joshi, S. (2023) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2023.127245 · Cited by 51
Focal adhesion kinase signaling – tumor vulnerabilities and clinical opportunities
Schlaepfer, D. D., Ojalill, M., & Stupack, D. G. (2024) · Journal of Cell Science · doi:10.1242/jcs.261723 · Cited by 55
Self-citationLu, K., Chen, P., Hsieh, Y., Lin, C.-Y., Cheng, F.-Y., Chiu, P.-C., Chu, S., & Hsieh, Y. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.09.006 · Cited by 51
Dendritic cells maintain dermal adipose–derived stromal cells in skin fibrosis
Chia, D. J., Zhu, T., Chyou, S., Dasoveanu, D., Carballo, C. B., Tian, S., MAGRO, C. M. J., Rodeo, S. A., Spiera, R., Ruddle, N. H., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85740 · Cited by 52
Furuta, T., Sabit, H., Dong, Y. J., Miyashita, K., Kinoshita, M., Uchiyama, N., Hayashi, Y., Hayashi, Y., Minamoto, T., & Nakada, M. (2017) · Oncotarget · doi:10.18632/oncotarget.15206 · Cited by 51
Focal Adhesion Kinase and β‐Catenin Cooperate to Induce Hepatocellular Carcinoma
Shang, N., Wang, H., Bank, T., Perera, A., Joyce, C., Kuffel, G. R., Zilliox, M. J., Cotler, S. J., Ding, X., Dhanarajan, A. R., et al. (2019) · Hepatology · doi:10.1002/hep.30707 · Cited by 51
Immunotherapy of pancreatic cancer
Sunami, Y., & Kleeff, J. H. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.03.006 · Cited by 52
Liu, Y., Sun, L. J., Li, Y., & Holmes, C. A. (2024) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12472 · Cited by 50
Chikano, Y., Domoto, T., Furuta, T., Sabit, H., Kitano-Tamura, A., Pyko, I. V., Takino, T., Sai, Y., Hayashi, Y., Sato, H., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0479 · Cited by 50
Precision Immuno-Oncology: Prospects of Individualized Immunotherapy for Pancreatic Cancer
Zhang, J., Wolfgang, C. L., & Zheng, L. (2018) · Cancers · doi:10.3390/cancers10020039 · Cited by 52
Zhao, T., Li, R., Tan, X., Zhang, J., Fan, C., Zhao, Q., Deng, Y., Xu, A., Lukong, K. E., Genth, H., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071994 · Cited by 54
Tong, X., Tanino, R., Sun, R., Tsubata, Y., Okimoto, T., Takechi, M., & Isobe, T. (2019) · Respiratory Research · doi:10.1186/s12931-019-1244-2 · Cited by 50
Focal adhesion kinase: Insight into its roles and therapeutic potential in oesophageal cancer
Zhang, Y., Liu, S., Zhou, S. F., Yu, D., Gu, J., Qin, Q., Cheng, Y., & Sun, X. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.10.005 · Cited by 50
Metadata
- Authors
- Sulzmaier, F. J., Jean, C., & Schlaepfer, D. D.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Schlaepfer, David D.
- Venue
- Nature Reviews Cancer
- Published
- 2014-08-07
- Volume
- 14
- Issue
- 9
- Pages
- 598-610
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC4365862
- OpenAlex
- W2044423100
- Cited by
- 1,381
- References
- 142
- Citations by year
- 2026: 92 · 2025: 85 · 2024: 131 · 2023: 111 · 2022: 147 · 2021: 154 · 2020: 144 · 2019: 122 · 2018: 105 · 2017: 128 · 2016: 91 · 2015: 63 · 2014: 6
- FWCI
- 12.73
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- American Heart Association
- Verastem Oncology
- National Institutes of Health
- National Cancer Institute (R01CA102310, CA102310, R01CA180769, CA180769, T32CA121938)
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- focal adhesion kinase, FAK inhibitors, tumor microenvironment, tumor stromal cells, metastasis, tumor progression, cancer stem cells, cell invasion, cell migration, small molecule inhibitors, clinical development
- MeSH terms
- Animals, Humans, Neoplasm Invasiveness, Neoplasms, Signal Transduction, Stromal Cells, Protein Kinase Inhibitors, Focal Adhesion Kinase 1, Small Molecule Libraries, Molecular Targeted Therapy, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review